Cargando…

Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure

BACKGROUND: Results of recent clinical trials have shown that in heart failure (HF) heart rate (HR) values > 70 beats/minute are associated with an increased cardiovascular risk. No information is available on whether the sympathetic nervous system is differently activated in HF patients displayi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grassi, Guido, Seravalle, Gino, Vanoli, Jennifer, Facchetti, Rita, Spaziani, Domenico, Mancia, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849312/ https://www.ncbi.nlm.nih.gov/pubmed/35552503 http://dx.doi.org/10.1007/s00392-022-02028-9

Ejemplares similares

Correction: Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
por: Grassi, Guido, et al.
Publicado: (2022)

Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome
por: Seravalle, Gino, et al.
Publicado: (2022)

Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report
por: Dell’Oro, Raffaella, et al.
Publicado: (2017)

Elevated resting heart rate as independent in-hospital prognostic marker in COVID-19
por: Vanoli, Jennifer, et al.
Publicado: (2022)

Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure
por: Quarti‐Trevano, Fosca, et al.
Publicado: (2021)

Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement
por: Grassi, Guido, et al.
Publicado: (2021)

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study
por: Gronda, Edoardo, et al.
Publicado: (2014)

Correction: New-onset aortic dilatation in the population: a quarter-century follow-up
por: Cuspidi, Cesare, et al.
Publicado: (2022)

New-onset aortic dilatation in the population: a quarter-century follow-up
por: Cuspidi, Cesare, et al.
Publicado: (2022)

Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study
por: Grassi, Guido, et al.
Publicado: (2022)

Uric acid relationships with lipid profile and adiposity indices: Impact of different hyperuricemic thresholds
por: Maloberti, Alessandro, et al.
Publicado: (2022)

Sympathetic activation in heart failure( )
por: Gronda, E, et al.
Publicado: (2022)

Clinical Relevance of the Sympathetic–Vascular Interactions in Health and Disease
por: Quarti-Trevano, Fosca, et al.
Publicado: (2021)

Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation
por: Quarti-Trevano, Fosca, et al.
Publicado: (2021)

Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease
por: Seravalle, Gino, et al.
Publicado: (2021)

Association between Berlin questionnaire index and blood pressure, organ damage and metabolic profilein a general population
por: Vanoli, Jennifer, et al.
Publicado: (2022)

Sympathetic regulation of vascular function in health and disease
por: Bruno, Rosa M., et al.
Publicado: (2012)

Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy
por: Bombelli, Michele, et al.
Publicado: (2023)

Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension
por: Dell’Oro, Raffaella, et al.
Publicado: (2023)

Endothelial, Vascular and Sympathetic Alterations as Therapeutic Targets in Chronic Heart Failure
por: Quarti-Trevano, Fosca, et al.
Publicado: (2023)

White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020
por: Mancia, Giuseppe, et al.
Publicado: (2021)

Anthropometric Measures of Adiposity as Markers of Kidney Dysfunction: A Cross-Sectional Study
por: Vela-Bernal, Sara, et al.
Publicado: (2023)

Sympathetic Neural Mechanisms in Hypertension: Recent Insights
por: Grassi, Guido, et al.
Publicado: (2023)

Regulation of the renal sympathetic nerves in heart failure
por: Ramchandra, Rohit, et al.
Publicado: (2015)

Reconsidering Renal Sympathetic Denervation for Heart Failure
por: Tang, W.H. Wilson, et al.
Publicado: (2017)

Should White-Coat Hypertension in Diabetes Be Treated? Pro
por: Mancia, Giuseppe, et al.
Publicado: (2009)

Short- and Long-Term Reproducibility of Nighttime Blood Pressure Phenotypes and Nocturnal Blood Pressure Reduction
por: Mancia, Giuseppe, et al.
Publicado: (2021)

Stellate Ganglia and Cardiac Sympathetic Overactivation in Heart Failure
por: Li, Yu-Long
Publicado: (2022)

Heart Rate Variability and Sympathetic Activity Is Modulated by Very Low-Calorie Ketogenic Diet
por: Polito, Rita, et al.
Publicado: (2022)

Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance
por: Cohen‐Solal, Alain, et al.
Publicado: (2017)

Respiratory patterns and baroreflex function in heart failure
por: Radaelli, Alberto, et al.
Publicado: (2023)

Heart rate – A complex prognostic marker in acute heart failure
por: Olligs, Jan, et al.
Publicado: (2019)

Enhanced sympathetic activity and cardiac sympathetic afferent reflex in rats with heart failure induced by adriamycin
por: Zhang, Shujuan, et al.
Publicado: (2012)

The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF
por: Triposkiadis, Filippos, et al.
Publicado: (2023)

Constant Light Exerted Detrimental Cardiovascular Effects Through Sympathetic Hyperactivity in Normal and Heart Failure Rats
por: Jing, Jia-Ni, et al.
Publicado: (2020)

Lercanidipine in the Management of Hypertension: An Update
por: Grassi, Guido, et al.
Publicado: (2017)

Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
por: Gronda, Edoardo G., et al.
Publicado: (2022)

Sympathetic and hemodynamic responses to exercise in heart failure with preserved ejection fraction
por: Manabe, Kazumasa, et al.
Publicado: (2023)

Heart rate and blood pressure monitoring in heart failure
por: Ponikowski, Piotr, et al.
Publicado: (2019)

Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers
por: Borovac, Josip Anđelo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i7rtspp7mp2jadrmtsvnr6vidh